Ophthalmic Viscosurgical Devices Market Analysis | Europe | 2017-2023 | MedCore
- Year: 2017
- Scope: 2013-2023
- Region: Europe
- Pages: 71
- Published Date: 11/1/2016
- Type: MedCore
The OVD market is expected to grow slightly throughout the forecast period. Demand for OVDs will be driven by the aging population and the associated need for refractive correction among this demographic. OVD use is directly correlated with IOL sales. In general, growth of the IOL market is driven by the increasing prevalence of cataracts, a condition that is associated with older age. Since standard monofocal IOLs are covered by most government health insurance overall IOL insertion rates do not depend on economic stability. Because of this, procedure rates should remain constant as should OVD use.
Ophthalmic viscosurgical devices (OVD) are viscoelastic solutions used in several eye surgeries. They are also referred to as viscoelastic agents. These fluids have had a great influence on both extracapsular and phacoemulsification surgeries and their use has decreased the incidence of corneal edema. The main task of the OVD is protecting the inner side of the cornea during surgery. It accomplishes this by maintaining a deep anterior chamber during anterior segment surgery.
Segments Covered in This Market
- Ophthalmic Viscosurgical Device Market
Report Data Types Included
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares
- Product Portfolios
- Related Press Releases from Top Competitors
Companies Analyzed
Of the many companies in the European Ophthalmic Viscosurgical Device market, Abbott Medical Optics (AMO) is the leader, followed by Alcon and Bausch & Lomb. AMOs OVD sales are strongly tied to the success of their IOL sales and thus, as expected, have strong OVD sales in the same countries in which they have a strong IOL presence. Other companies analyzed include Carl Zeiss Meditec.
About Our In-Depth MedCore Research
Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.
This MedCore is also found in the full report suite titled Europe Market Report Suite for Diagnostic and Interventional Ophthalmic Devices – MedSuite
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
Ophthalmic Viscosurgical Devices Market Analysis | Europe | 2017-2023 | MedCore
$295 – $6,995
Ophthalmic viscosurgical devices (OVD) are viscoelastic solutions used in several eye surgeries. They are also referred to as viscoelastic agents. These fluids have had a great influence on both extracapsular and phacoemulsification surgeries and their use has decreased the incidence of corneal edema. The main task of the OVD is protecting the inner side of the cornea during surgery. It accomplishes this by maintaining a deep anterior chamber during anterior segment surgery. This space prevents contact with and possible damage to the endothelial cell layer on the inner side of the cornea and the surrounding ocular tissues. In addition OVDs help to push back the vitreous face in the event of a posterior capsule tear or a rent in the zonules all the while preventing formation of a flat chamber during surgery.
- 2017
- 2013-2023
- Europe
- 11/1/2016
- 71
- MedCore
